Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NETWORK × spartalizumab × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

OTHER 37 INDUSTRY 12 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Specimen Handling 27 Magnetic Resonance Spectroscopy 20 Radiation 10 Cyclophosphamide 10 Carboplatin 10 Biopsy 9 Cisplatin 8 daratumumab 7 Vincristine 7 Radiotherapy 7 Lenalidomide 7 Etoposide 7 Dexamethasone 7 durvalumab 6 Radiosurgery 6 Observation 6 Leucovorin 6 Irinotecan 6 pembrolizumab 5 X-Rays 5 Surgical Procedures, Operative 5 Platinum 5 Interviews as Topic 5 Gemcitabine 5 Doxorubicin 5 1,2-diaminocyclohexaneplatinum II citrate 5 Watchful Waiting 4 Radiotherapy, Intensity-Modulated 4 Proton Therapy 4 Methotrexate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06758037 2025-03-18

HiR+X

First Affiliated Hospital of Ningbo University

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡